Conference Description
The Immunoengineering GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Immunoengineering integrates principles from engineering and the physical sciences with immunology to develop transformative solutions for human health. Breakthroughs in engineered immune cells (e.g., CAR-T cells), antibodies, nucleic acid-based therapies, biomaterials and nanotechnology have revolutionized treatments for cancer, infectious diseases, and autoimmune disorders. The field continues to expand, with novel vaccine platforms and immune-modulating technologies pushing the boundaries of medicine. At the same time, emerging tools are providing deeper insights into the immune mechanisms underlying disease and revealing new strategies to restore normal immune function. Building on the success of previous meetings, the 2026 conference will provide a collaborative space to discuss molecular, cellular, and tissue-scale advances, translational applications, and emerging trends in immunoengineering to advance medicine. We invite researchers at all career stages to apply and contribute to shaping the future of this dynamic field. Join us for an immersive experience that sparks new ideas, builds connections, and propels immunoengineering forward.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by May 28, 2025. Please check back for updates.
